Research & Development (Pharma & Healthcare)

Pharma & Healthcare R&D Reports

Research & Development (Pharma & Healthcare) Market Research Reports, Industry Analysis and Trends

 

Publication Single User License (PDF) Price
New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

Date Published: Jan 20 2015
The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous efforts by the JP government to promote increased use of generics (started in 2006 by launching various benefits for GE use at Pharmacy, hospital level) – now in 2014, Generic penetration of small molecules is changing the trend line and moving towards faster market penetration.
$4,000.00
Infectious Vaccines Partnering Terms and Agreements

Infectious Vaccines Partnering Terms and Agreements

Date Published: Jan 1 2015
The Infectious Vaccines Partnering Terms and Agreements provides comprehensive understanding and unprecedented access to the infectious vaccines partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

$1,995.00
Antibiotics Partnering Terms and Agreements

Antibiotics Partnering Terms and Agreements

Date Published: Jan 1 2015
The Antibiotics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibiotic partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.
$1,995.00
U.S. Orthopedic Biomaterials Market - 2015

U.S. Orthopedic Biomaterials Market - 2015

Date Published: Jan 1 2015
The fastest growing segments involve stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential for healing bone.
 
$6,995.00
Antibody Partnering Terms and Agreements

Antibody Partnering Terms and Agreements

Date Published: Jan 1 2015
The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
 

Description

The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
$2,995.00
Global Transdermal Drug Delivery Market to 2017

Global Transdermal Drug Delivery Market to 2017

Date Published: Dec 8 2014

Global Transdermal Drug Delivery Market to 2017: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation

$3,560.00
Oncology Partnering Terms and Agreements

Oncology Partnering Terms and Agreements

Date Published: Dec 1 2014
The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies
 

Description

The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology/cancer partnering deals and agreements entered into by the worlds leading healthcare companies.
$2,995.00
Ophthalmics Partnering Terms & Agreements

Ophthalmics Partnering Terms & Agreements

Date Published: Dec 1 2014
The Ophthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter ophthalmics partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right tlicense the licensors ophthalmics technology. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes.
 
$1,995.00
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies.

Description
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

$1,995.00
Dermatology Partnering Terms and Agreements

Dermatology Partnering Terms and Agreements

Date Published: Dec 1 2014
The Dermatology Partnering Terms and Agreementsreport provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals. 
The majority of deals are marketed stage deals whereby the licensee obtains a marketing right or an option tcmarket or market the licensors dermatology product candidates. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes. 
 
$2,995.00
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

$2,995.00
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies

$3,295.00
Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

Date Published: Dec 1 2014

The Gene Therapy Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Vaccine Partnering Agreements Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
Cancer Diagnostics Partnering Terms and Agreements

Cancer Diagnostics Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

$2,995.00
Opioids Market Overview to 2023 - Opioids in Emerging Markets

Opioids Market Overview to 2023 - Opioids in Emerging Markets

Date Published: Nov 30 2014
Opioids Market Overview to 2023 Opioids in Emerging Markets report provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa). Access to opioids is restricted under strict drug control policies and regulations overseeing controlled medicines due to their high abuse potential.
$2,995.00
Global Sexually Transmitted Diseases (STDs) Testing Market (Disease Types, Testing Volume, Testing Devices and Geography) - Industry Analysis and Forecast, 2013 - 2020

Global Sexually Transmitted Diseases (STDs) Testing Market (Disease Types, Testing Volume, Testing Devices and Geography) - Industry Analysis and Forecast, 2013 - 2020

Date Published: Nov 14 2014
Sexually Transmitted Diseases (STDs) are also known as Venereal diseases (VDs) or Sexually Transmitted Infections (STIs). A variety of methods have been employed for diagnosis of STDs that differ based on the type of disease. The objective of this report is to provide an in-depth understanding of diagnostic tests of STDs. The market diagnostic testing of STDs was valued at $96.7 billion in 2013 with a corresponding test volume of 4,204 million.
$4,515.00
Global Neuroprosthetics Market (Product Types, Technology, Application, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Global Neuroprosthetics Market (Product Types, Technology, Application, and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Date Published: Nov 14 2014
Neuroprosthetics, also referred to as neural implants/brain implants, have gained significant momentum during past few years owing to the immense potential to substitute and/or ameliorate any damaged sensory, motor or cognitive functions. Such Neuroprosthetics are the key to restore and/or augment the ‘quality-of-life’ of the affected patient populace. The Neuroprosthetics, as therapeutic modalities, are emerging as a promising option in cases where all conventional treatments fail to deliver results/treatment to the disease condition.
$4,515.00
Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Global COPD and Asthma Devices Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Date Published: Nov 14 2014
The COPD and Asthma hold the largest market share within the global respiratory diseases’ market. As estimated by Global Initiative for Asthma (GINA), approximately 300 million people suffer from Asthma globally. COPD was the 3rd leading cause for death with 3 million people in 2013. Variety of drug-delivery methods such as oral and parenteral delivery have been deployed for treatment of COPD and Asthma; however, the pulmonary drug delivery system is the most effective drug-delivery technology as compared to the other (stated) conventional methods.
$2,850.00
Global Catheters Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Global Catheters Market (Product Types and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Date Published: Nov 14 2014
Catheters are thin tubes made up of medical grade material such as plastic, silicon rubber, PVC and nylon that are inserted in the patient’s body for therapeutic and diagnostic purposes. Catheterization is a primary co-procedure along with varied other medical procedures such as angioplasty, cardiac electrophysiology, and neurosurgery among others. Catheters are the vital component in several surgical procedures. The global catheters market is primarily driven by increasing cardiovascular diseases and growing demand for minimal invasive surgeries.
$4,515.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data